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209 МОЛЕКУЛЯРНО-ГЕНЕТИЧНІ ОСНОВИ ПАТОЛОГІЧНИХ ПРОЦЕСІВ ТА ХВОРОБ 
FREQUENCIES OF VKORC1 G3730A GENETIC VARIANTS IN ISCHEMIC 
ATHEROTHROMBOTIC STROKE PATIENTS 
Garbuzova E.A., Dubovyk Ye.I., Ataman O.V. 
Sumy State University, Physiology and Pathophysiology Department 
Background. Vitamin K epoxide reductase (VKOR) is an integral membrane protein that 
catalyzes the reduction of vitamin K 2,3-epoxide and vitamin K to vitamin K hydroquinone, a cofactor 
required for the G-glutamyl carboxylation reaction. VKOR is highly sensitive to inhibition by 
warfarin, the most commonly prescribed oral anticoagulant. A lifelong decreased activity of the 
VKOR enzyme, however, might impair MGP activity and by this increase the risk of vascular 
calcification. The VKORC1 gene is located on the short arm of chromosome 16 (chromosomal 
location: 16p11.2). Polymorphisms in the VKORC1 could affect blood coagulation and other vitamin 
K-dependent proteins, such as osteocalcin, bone Gla protein, matrix Gla protein.  
Purpose. Study of frequencies of VKORC1 G3730A genetic variants in ischemic 
atherothrombotic stroke (IAS) patients. 
Materials and Methods. The study was conducted using venous blood of 170 patients with 
IAS (57,6% men and 42,4% women), the average age of 64,7±0,73 years. The control group consisted 
of 124 healthy donors, and the absence of cardiovascular diseases was confirmed through history, 
electrocardiogram data and arterial pressure measurements. DNA was isolated from it using a set of 
"Isogene" (Russia). The polymorphism G3730A (rs7294) was analyzed by amplification of a 500-bp 
sequence with the use of the following primers: sence – 5`-GTCCCTAGAAGGCCCTAGATGT-3`, 
antisense – 5`-GTGTGGCACATTTGGTCCATT-3`. The resultant polymerase chain reaction 
products were digested with BseNI (Thermo Scientific, USA), which yielded 2 DNA fragments of 
260 and 240 bp for the G allele on 2,5% agarose gel and only 1 band (500 bp) for the A allele. The 
results were worked out statistically using the official average of SPSS Statistics 17.0. For this 
purpose, reliability of differences was determined using χ 2 - test. The value of P < 0.05 was 
considered reliable. 
Results. Genotyping of the patients with IAS and comparing the results obtained with those 
of restriction analysis in the control group allowed to set that frequency of definite variants of this 
gene is statistically insignificant in G3730A polymorphism. It has been found that the ratio of 
homozygotes by the major allele, heterozygotes and homozygotes by the minor alleles in G3730A 
polymorphism constituted in patients with IAS: 31,8%, 50,0%, 18,2%; and in the control group it was 
36,3%, 50,8%, 12,9% (P = 0,423, χ2 = 1,721).   
Conclusions. No association has been found between the G3730A polymorphism of  
VKORC1 gene and ischemic atherothrombotic stroke in the patients from the northeastern region of 
Ukraine.  
 
ASSOCIATION TaqI POLYMORPHISM OF VDR GENE IN SMOKERS AND NON-
SMOKERS, AMONG PATIENTS WITH ISCHEMIC STROKE 
Obukhova О.А. 
Sumy State University, Physiology and Pathophysiology Department 
Study by WHO is shown that traditional approaches in the treatment of ischemic stroke are 
ineffective and lead to significant economic costs. The problem of low efficiency of health care 
activities is related to the absence of their etiological orientation due to insufficient understanding of 
the major mechanisms of formation of cerebrovascular disorders. It is projected that until 2030 
morbidity stroke will increase by 25%, due to the aging of the world population and increasing 
prevalence in the population of brain stroke risk factors like hypertension, heart disease, diabetes, 
physical inactivity, obesity, smoking, and others. 
The aim of our study was to analyze the association of TaqI polymorphism of VDR gene in 
smokers and non-smokers patients with atherothrombotic ischemic stroke. 
Venous blood of 170 patients with atherothrombotic ischemic stroke (AIS) and 124 healthy 
individuals (control group) was used for genotyping. Pathogenetic variants of stroke was determined 
